Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Date Filed |
---|
Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Date Filed |
---|---|---|---|---|---|---|---|---|
Q3 2024 | 27 | $7.22M | +$4.45M | -$4.38M | +$65.5K | VANI, VLCN, HCWC, IMNN, CORZ | 13F-HR | 11/14/2024, 08:11 AM |
Q2 2024 | 27 | $7.53M | +$2.77M | -$7.6M | -$4.84M | VANI, CORZW, RDHL, GWAV, ELTK | 13F-HR | 8/14/2024, 07:08 AM |
Q1 2024 | 44 | $14.4M | +$12.7M | -$8.2M | +$4.52M | VANI, ELTK, RDHL, GMM, CHNR | 13F-HR | 5/15/2024, 07:51 AM |
Q4 2023 | 46 | $11.3M | +$7.49M | -$25.7M | -$18.2M | TNXP, BCAN, MMAT, PHUN, RCON | 13F-HR | 2/14/2024, 06:44 AM |
Q3 2023 | 66 | $31.6M | +$23M | -$41.4M | -$18.4M | IWM, SPY, SEEL, TC, RCON | 13F-HR | 11/14/2023, 07:25 AM |
Q2 2023 | 68 | $27.7M | +$16.1M | -$13.8M | +$2.32M | BIOR, SONN, AKTX, SIDU, RCON | 13F-HR | 8/14/2023, 05:17 PM |
Q1 2023 | 72 | $26.9M | +$16M | -$22.8M | -$6.74M | NMTRQ, AKTX, TC, DOGZ, RCON | 13F-HR | 5/15/2023, 09:09 AM |
Q4 2022 | 89 | $37.3M | +$15.9M | -$14.4M | +$1.49M | NVCT, TBLT, DOGZ, TC, IWM | 13F-HR | 2/14/2023, 08:40 AM |
Q3 2022 | 83 | $47.4M | +$24.2M | -$27M | -$2.74M | BGXX, NVCT, DOGZ, BLRX, AKTX | 13F-HR | 11/14/2022, 09:28 AM |
Q2 2022 | 76 | $53.8M | +$25.4M | -$187M | -$161M | GEVO, DOGZ, MMAT, COCP, PMCB | 13F-HR | 8/15/2022, 08:16 AM |
Q1 2022 | 85 | $233M | +$16.3M | -$108M | -$91.4M | COCP, PMCB, BIVI, NISN, CNTX | 13F-HR | 5/16/2022, 08:34 AM |
Q4 2021 | 105 | $177M | +$83.2M | -$50.5M | +$32.7M | BTBT, NISN, SRNE, ESPR, VXX | 13F-HR | 2/14/2022, 07:54 AM |
Q3 2021 | 94 | $180M | +$110M | -$54.8M | +$54.8M | BTBT, BTCM, SRNE, VXX, COCP | 13F-HR | 11/15/2021, 08:25 AM |
Q2 2021 | 85 | $142M | +$69.2M | -$49.8M | +$19.4M | SRNE, COCP, RENB, ATOS, ATER | 13F-HR | 8/16/2021, 09:14 AM |
Q1 2021 | 82 | $136M | +$124M | -$88M | +$36.5M | SRNE, EYES, ASXC, NBEVQ, WIMI | 13F-HR | 5/14/2021, 05:44 PM |
Q4 2020 | 53 | $104M | +$55.5M | -$63.6M | -$8.14M | BIIB, AZN, MRNA, XWEL, CVM | 13F-HR | 2/16/2021, 09:00 AM |
Q3 2020 | 69 | $111M | +$81M | -$47.8M | +$33.2M | BIIB, MRNA, AZN, SRNE, IMMU | 13F-HR | 11/16/2020, 09:09 AM |
Q2 2020 | 50 | $77M | +$67.4M | -$23.3M | +$44.2M | BIIB, XLV, MRNA, XERS, PLL | 13F-HR | 8/14/2020, 08:48 AM |
Q1 2020 | 57 | $28.9M | +$18.9M | -$15.4M | +$3.43M | XLV, GLD, NOVN, ENLV, OTLK | 13F-HR | 5/15/2020, 05:00 PM |
Q4 2019 | 49 | $26.9M | +$14.6M | -$21.4M | -$6.81M | GLD, ONTX, ODTC, GNCA, BPTH | 13F-HR | 2/14/2020, 04:11 PM |
Q3 2019 | 65 | $35.7M | +$16.6M | -$12.8M | +$3.84M | TEUM, ODTC, ATNM, CRMD, CJJD | 13F-HR | 11/14/2019, 06:17 PM |
Q2 2019 | 65 | $38.4M | +$24M | -$17.9M | +$6.14M | ODTC, ATNM, AMPE, CJJD, GNCA | 13F-HR | 8/14/2019, 04:04 PM |
Q1 2019 | 53 | $32.1M | +$8.46M | -$73.9M | -$65.5M | ODTC, BCLI, ORMP, LOOP, SOLO | 13F-HR | 5/15/2019, 05:10 PM |
Q4 2018 | 86 | $93.6M | +$51.3M | -$33M | +$18.3M | BIIB, ESPR, XBI, BCLI, XERS | 13F-HR | 2/13/2019, 05:56 PM |
Q3 2018 | 75 | $112M | +$25.1M | -$87.8M | -$62.6M | NKTR, BIIB, ODTC, XERS, UMRX | 13F-HR | 11/13/2018, 06:14 PM |
Q2 2018 | 84 | $174M | +$83.2M | -$60.3M | +$22.9M | BIIB, NVO, ODTC, NKTR, XERS | 13F-HR | 8/14/2018, 08:48 AM |
Q1 2018 | 86 | $156M | +$118M | -$113M | +$4.94M | BIIB, ODTC, SPY, UMRX, INCY | Restatement | 5/15/2018, 03:35 PM |
Q4 2017 | 79 | $145M | +$64.7M | -$36.6M | +$28.1M | BMY, ODTC, ESPR, ONCE, MNKD | Restatement | 2/15/2018, 02:15 PM |
Q3 2017 | 79 | $122M | +$87.6M | -$180M | -$92.3M | BMY, AXGT, ESPR, ONS, GWPH | 13F-HR | 11/14/2017, 09:32 AM |
Q2 2017 | 112 | $218M | +$163M | -$77.4M | +$85.3M | TSRO, UTHR, SGEN, BIOAQ, SPNC | Restatement | 9/27/2017, 11:49 AM |
Q1 2017 | 123 | $142M | +$52.2M | -$244M | -$192M | BMY, AMGN, ONS, IONS, MTFB | Restatement | 5/16/2017, 10:09 AM |
Q4 2016 | 152 | $332M | +$183M | -$73.3M | +$110M | REGN, SRPT, AMGN, BMY, LLY | 13F-HR | 2/13/2017, 06:55 PM |
Q3 2016 | 143 | $277M | +$70.2M | -$126M | -$55.8M | SRPT, REGN, AMGN, ONS, BMY | 13F-HR | 11/14/2016, 09:37 AM |
Q2 2016 | 148 | $288M | +$125M | -$124M | +$757K | REGN, AMGN, SRPT, ABT, ONS | 13F-HR | 8/15/2016, 10:06 AM |
Q1 2016 | 166 | $300M | +$195M | -$138M | +$56.9M | SPY, AMGN, REGN, SRPT, BIIB | 13F-HR | 5/13/2016, 04:54 PM |
Q4 2015 | 152 | $287M | +$109M | -$289M | -$180M | IWM, GWPH, ALKS, VPCOU, TENX | 13F-HR | 2/16/2016, 09:37 AM |
Q3 2015 | 194 | $488M | +$315M | -$163M | +$152M | IWM, BIIB, BMRN, MYL, PXD | 13F-HR | 11/16/2015, 10:06 AM |
Q2 2015 | 137 | $395M | +$242M | -$197M | +$45.5M | TLT, MRK, GBSNU, XOM, PXD | 13F-HR | 8/14/2015, 11:17 AM |
Q1 2015 | 123 | $353M | +$221M | -$210M | +$10.7M | B108PS, IWM, ZGNX, MBBYF, IOC | 13F-HR | 5/15/2015, 09:25 AM |
Q4 2014 | 102 | $341M | +$196M | -$82.5M | +$114M | PFE, ACAD, B108PS, AZN, IOC | 13F-HR | 2/17/2015, 06:19 AM |
Q3 2014 | 106 | $206M | +$138M | -$239M | -$101M | B108PS, IOC, TENX, GEVA, TSLA | Restatement | 11/18/2014, 04:03 PM |
Q2 2014 | 100 | $332M | +$221M | -$86.4M | +$134M | WY, TEVA, REGN, ACAD, OXBT | 13F-HR | 8/14/2014, 09:58 AM |
Q1 2014 | 82 | $206M | +$138M | -$105M | +$32.2M | TEVA, OXBT, ACAD, GILD, BPTH | 13F-HR | 5/13/2014, 05:47 PM |
Q4 2013 | 76 | $168M | $0 | $0 | MNKD, TEVA, ACAD, SRPT, AEGR | 13F-HR | 2/13/2014, 07:03 PM |